Resistance to Targeted Therapies in Lymphomas

  • Ana C. Xavier
  • Mitchell S. Cairo

Part of the Resistance to Targeted Anti-Cancer Therapeutics book series (RTACT, volume 21)

Table of contents

  1. Front Matter
    Pages i-xx
  2. Lauren K. Meyer, Michelle L. Hermiston
    Pages 1-26
  3. Matthew J. Barth, Stanton C. Goldman
    Pages 27-55
  4. Jessica Hochberg, Sarah Alexander
    Pages 57-69
  5. Rodney R. Miles, Paul J. Galardy
    Pages 71-86
  6. Yaya Chu, Mitchell S. Cairo, Auke Beishuizen
    Pages 111-153
  7. Anthony N. Audino, Mitchell S. Cairo
    Pages 155-179
  8. Stacy L. Cooper, Patrick A. Brown
    Pages 181-192
  9. Ana C. Xavier, Luciano J. Costa
    Pages 193-203
  10. Back Matter
    Pages 205-210

About this book


This volume will review different classes of "target" drugs that have been developed, approved, or are under investigation in the field of lymphoma therapy. The discussion will not only be on the understanding of the mechanisms of action or clinical response of those agents, but also help the reader to understand the nature of lymphoma biology in patients who relapse or are refractor after exposure to those drugs. Contributors will discuss what is currently known about mechanisms of tumor-related or host-related resistance, and how to overcome this resistance. This understanding is crucial given the dismal outcomes of patients with relapsed or refractory lymphomas. The book provides a unique opportunity to review and reflect on the recent successes and pitfalls of the modern lymphoma therapy era. 


lymphoma hodgkin lymphoma B-cell lymphomas T-cell lymphomas indolent lymphomas

Editors and affiliations

  • Ana C. Xavier
    • 1
  • Mitchell S. Cairo
    • 2
  1. 1.Division of Hematology/Oncology, Department of PediatricsUniversity of Alabama at Birmingham Children’s Hospital of AlabamaBirminghamUSA
  2. 2.Departments of Pediatrics, Medicine, Pathology, Microbiology and Immunology, Cell Biology and AnatomyNew York Medical CollegeValhallaUSA

Bibliographic information

Industry Sectors
Health & Hospitals
Oncology & Hematology
Consumer Packaged Goods